News
BPTSY
1.380
NaN%
--
Weekly Report: what happened at BPTSY last week (0420-0424)?
Weekly Report · 3d ago
Weekly Report: what happened at BPTSY last week (0413-0417)?
Weekly Report · 04/20 09:30
Weekly Report: what happened at BPTSY last week (0406-0410)?
Weekly Report · 04/13 09:31
Weekly Report: what happened at BPTSY last week (0330-0403)?
Weekly Report · 04/06 09:31
Weekly Report: what happened at BPTSY last week (0323-0327)?
Weekly Report · 03/30 09:31
Biophytis Showcases AI-Driven Longevity Drug Discovery with LynxKite at NVIDIA GTC 2026
TipRanks · 03/26 18:18
Weekly Report: what happened at BPTSY last week (0316-0320)?
Weekly Report · 03/23 09:30
Weekly Report: what happened at BPTSY last week (0309-0313)?
Weekly Report · 03/16 09:29
Biophytis Raises €2 Million, Clears Convertible Debt to Fund Longevity Trials
TipRanks · 03/11 10:58
Weekly Report: what happened at BPTSY last week (0302-0306)?
Weekly Report · 03/09 09:30
Weekly Report: what happened at BPTSY last week (0223-0227)?
Weekly Report · 03/02 09:30
Biophytis Doubles Hexagon Bond Facility to €2 Million and Extends Maturity
TipRanks · 02/27 20:27
Weekly Report: what happened at BPTSY last week (0216-0220)?
Weekly Report · 02/23 09:30
Weekly Report: what happened at BPTSY last week (0209-0213)?
Weekly Report · 02/16 09:30
Biophytis Targets Muscle Loss in GLP-1 Weight Loss Users With New Phase 2 Trial
TipRanks · 02/13 16:31
Weekly Report: what happened at BPTSY last week (0202-0206)?
Weekly Report · 02/09 09:30
Weekly Report: what happened at BPTSY last week (0126-0130)?
Weekly Report · 02/02 09:30
Biophytis Strikes Asia Joint Venture and Secures $20 Million to Fund Phase 3 Sarcopenia Trial
TipRanks · 01/28 15:27
Weekly Report: what happened at BPTSY last week (0119-0123)?
Weekly Report · 01/26 09:30
Weekly Report: what happened at BPTSY last week (0112-0116)?
Weekly Report · 01/19 09:33
More
Webull provides a variety of real-time BPTSY stock news. You can receive the latest news about Biophytis Sa through multiple platforms. This information may help you make smarter investment decisions.
About BPTSY
Biophytis SA, formerly Institut Biophytis Sas is a France-based company engaged in the healthcare industry. The Company is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.